ALR TECHNOLOGIES SG LTD - ALRTF STOCK NEWS

Welcome to our dedicated page for ALR TECHNOLOGIES SG news (Ticker: ALRTF), a resource for investors and traders seeking the latest updates and insights on ALR TECHNOLOGIES SG stock.

ALR Technologies SG Ltd. (OTCQB: ALRTF) is a diabetes management company that has developed the ALRT Diabetes Solution, an FDA-cleared system for diabetes care. The system collects data from blood glucose meters and continuous glucose monitoring devices. The company's cornerstone is the Predictive A1c algorithm, which is designed to track treatment success and optimize diabetes drug therapies. The animal health division of ALRT has created the GluCurve Pet CGM to help veterinarians determine the efficacy of insulin treatments for companion animals. ALRT is dedicated to improving patient outcomes and providing innovative solutions for diabetes care.

09/28/2023 08:28 AM

News

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

Rhea-AI Summary

ALR Technologies announces patent grant for Predictive A1c diabetes management solution in Singapore and notice of allowance in the US. Successful completion of 24-week study shows a mean drop of 1.2% in HbA1c. Company expects to acquire intellectual property for Predictive A1c in the next 12 months.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-8.33%

Tags

08/07/2023 08:28 AM

News

ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

16.28%

Tags

06/01/2023 08:57 AM

News

ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

19.44%

Tags

01/12/2023 08:15 AM

News

Covetrus To Showcase Innovation and Technology at VMX 2023

Rhea-AI Summary

Covetrus will showcase its innovative technologies, including Pulse, the first cloud-based veterinary operating system, and the GluCurve Pet CGM, a continuous glucose monitoring system for diabetic pets, at VMX 2023 from January 14-18 in Orlando, Florida. Covetrus aims to address industry challenges through these offerings and will hold educational seminars focusing on practice management. The company also entered a co-branded distribution agreement with ALR Technologies SG Ltd (ALRTF) to enhance the availability of the GluCurve Pet CGM.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

27.27%

Tags

12/29/2022 08:28 AM

News

UPDATE: ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement

Rhea-AI Summary

ALR Technologies SG Ltd. (OTCQB:ALRTF) has secured a long-term manufacturing and supply agreement with Infinovo Medical Co. Ltd for distributing Continuous Glucose Monitor (CGM) hardware in the animal health market. This exclusive deal is expected to boost product availability and sales significantly in 2023. For December and Q4 2022, ALRT anticipates sales between $145,000 and $155,000, with Q1 2023 projected at $450,000 to $600,000. The company plans to increase production capacity and will showcase GluCurve at upcoming expos to enhance market visibility.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

7.98%

Tags

FAQ

What is the market cap of ALR TECHNOLOGIES SG (ALRTF)?

The market cap of ALR TECHNOLOGIES SG (ALRTF) is approximately 13.9M.

What is ALR Technologies SG Ltd.?

ALRT is a diabetes management company that offers the ALRT Diabetes Solution and the GluCurve Pet CGM for companion animals.

What is the ALRT Diabetes Solution?

The ALRT Diabetes Solution is an FDA-cleared system that collects data from blood glucose meters and continuous glucose monitoring devices to optimize diabetes drug therapies.

What is the Predictive A1c algorithm?

The Predictive A1c algorithm is a key component of ALRT's system, designed to track treatment success and provide best practice guidelines for diabetes care.

What is the GluCurve Pet CGM?

The GluCurve Pet CGM is a solution developed by ALRT's animal health division to assist veterinarians in determining the efficacy of insulin treatments for companion animals.

What are the goals of ALR Technologies SG Ltd.?

ALRT aims to improve patient outcomes by offering innovative solutions for diabetes care and optimizing drug therapies for both humans and companion animals.

Who is Sidney Chan?

Sidney Chan is the Chairman and CEO of ALRT and the owner of the Predictive A1c algorithm. The company has an informal license with Mr. Chan and expects to acquire the intellectual property in the next 12 months.

What recent achievements has ALR Technologies SG Ltd. announced?

ALRT has recently obtained a patent for the Predictive A1c algorithm, granted in Singapore and with a notice of allowance in the United States. The company has also completed a successful 24-week study with Singapore General Hospital, demonstrating a 1.2 percent drop in mean glycated hemoglobin for patients using the ALRT Diabetes Solution.

How can investors contact ALR Technologies SG Ltd.?

For investor relations inquiries, contact ir@alrt.com. For animal health inquiries, reach out to animalhealth@alrt.com. Media inquiries can be directed to media@alrt.com. Phone numbers for the US and Singapore offices are provided for additional contact information.

What is the focus of ALR Technologies SG Ltd.'s animal health division?

The animal health division of ALRT is dedicated to developing solutions that optimize diabetic drug therapies for companion animals, such as the GluCurve Pet CGM.

What steps has ALR Technologies SG Ltd. taken to protect its intellectual property?

ALRT has pursued patent applications for the Predictive A1c algorithm in multiple jurisdictions, with plans to acquire the intellectual property in the near future. The company aims to secure its competitive advantage and protect its clinically proven effective diabetes management system.